Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFred Alger Management, Llc
Latest Disclosed Ownership40,756 shares
Latest Disclosed Value $ 5,680,164
Fred Alger Management, Llc reports 70.71% increase in ownership of GILD / Gilead Sciences, Inc.

On May 15, 2026 - Fred Alger Management, Llc filed a 13F-HR form disclosing ownership of 40,756 shares of Gilead Sciences, Inc. (CH:GILD) valued at $5,680,164 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 23,875 shares of Gilead Sciences, Inc.. This represents a change in shares of 70.71% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F Gilead Sciences Equity 375558103 40,756 16,881 70.71 5,680 93.86 0.0159
2026-02-17 2025-12-31 13F Gilead Sciences Equity 375558103 23,875 -14,094 -37.12 2,930 -30.47 0.0115
2025-11-14 2025-09-30 13F Gilead Sciences Equity 375558103 37,969 -25,938 -40.59 4,215 -40.52 0.0164
2025-08-14 2025-06-30 13F Gilead Sciences Equity 375558103 63,907 30,724 92.59 7,085 90.56 0.0317
2025-05-16 2025-03-31 13F Gilead Sciences Equity 375558103 33,183 3,424 11.51 3,718 35.30 0.0212
2025-02-14 2024-12-31 13F Gilead Sciences Equity 375558103 29,759 2,402 8.78 2,749 19.84 0.0131
2024-11-14 2024-09-30 13F GILEAD SCIENCES Common 375558103 27,357 0 0.00 2,294 22.23 0.0111
2024-08-14 2024-06-30 13F GILEAD SCIENCES Common 375558103 27,357 2,442 9.80 1,877 2.79 0.0091
2024-05-15 2024-03-31 13F GILEAD SCIENCES Common 375558103 24,915 2,912 13.23 1,825 2.41 0.0090
2024-02-14 2023-12-31 13F GILEAD SCIENCES Common 375558103 22,003 1,165 5.59 1,782 14.16 0.0096
2023-11-14 2023-09-30 13F GILEAD SCIENCES Common 375558103 20,838 0 0.00 1,562 -2.74 0.0083
2023-11-14 2023-09-30 13F GILEAD SCIENCES Common 375558103 20,838 1,562
2023-08-14 2023-06-30 13F GILEAD SCIENCES Common 375558103 20,838 0 0.00 1,606 -7.12 0.0082
2023-05-16 2023-03-31 13F/A-1 GILEAD SCIENCES Common 375558103 20,838 1,010 5.09 1,729 1.53 0.0092
2023-05-15 2023-03-31 13F GILEAD SCIENCES Common 375558103 20,838 1,010 1,729 0.0086
2023-02-14 2022-12-31 13F GILEAD SCIENCES Common 375558103 19,828 1,344 7.27 1,702 49.30 0.0092
2022-11-15 2022-09-30 13F GILEAD SCIENCES Common 375558103 18,484 2,354 14.59 1,140 14.34 0.0058
2022-08-15 2022-06-30 13F GILEAD SCIENCES Common 375558103 16,130 483 3.09 997 7.20 0.0047
2022-05-16 2022-03-31 13F GILEAD SCIENCES Common 375558103 15,647 1,325 9.25 930 -10.58 0.0030
2022-02-14 2021-12-31 13F GILEAD SCIENCES Common 375558103 14,322 74 0.52 1,040 4.52 0.0026
2021-11-15 2021-09-30 13F GILEAD SCIENCES Common 375558103 14,248 0 0.00 995 1.43 0.0024
2021-08-16 2021-06-30 13F GILEAD SCIENCES Common 375558103 14,248 0 0.00 981 6.51 0.0023
2021-05-17 2021-03-31 13F GILEAD SCIENCES Common 375558103 14,248 -203 -1.40 921 9.38 0.0024
2021-02-16 2020-12-31 13F GILEAD SCIENCES Common 375558103 14,451 0 0.00 842 -7.78 0.0022
2020-11-13 2020-09-30 13F GILEAD SCIENCES Common 375558103 14,451 -30,260 -67.68 913 -73.46 0.0027
2020-08-14 2020-06-30 13F GILEAD SCIENCES Common 375558103 44,711 -616,737 -93.24 3,440 -93.04 0.0113
2020-05-19 2020-03-31 13F/A-1 GILEAD SCIENCES Common 375558103 661,448 646,665 4,374.38 49,450 5,045.68 0.2173
2020-05-15 2020-03-31 13F GILEAD SCIENCES Common 375558103 661,448 646,665 49,450 217,567.8971
2020-02-14 2019-12-31 13F GILEAD SCIENCES Common 375558103 14,783 0 0.00 961 2.56 0.0035
2019-11-14 2019-09-30 13F GILEAD SCIENCES Common 375558103 14,783 0 0.00 937 -6.21 0.0037
2019-08-14 2019-06-30 13F GILEAD SCIENCES Common 375558103 14,783 -361 -2.38 999 1.42 0.0038
2019-05-14 2019-03-31 13F GILEAD SCIENCES Common 375558103 15,144 -60,813 -80.06 985 -79.27 0.0039
2019-02-14 2018-12-31 13F GILEAD SCIENCES Common 375558103 75,957 24,939 48.88 4,751 20.61 0.0219
2018-11-14 2018-09-30 13F GILEAD SCIENCES Common 375558103 51,018 31,989 168.11 3,939 192.21 0.0148
2018-07-19 2018-06-30 13F GILEAD SCIENCES Common 375558103 19,029 2,729 16.74 1,348 9.68 0.0057
2018-05-10 2018-03-31 13F GILEAD SCIENCES Common 375558103 16,300 -12 -0.07 1,229 5.13 0.0057
2018-02-14 2017-12-31 13F GILEAD SCIENCES Common 375558103 16,312 -1,806 -9.97 1,169 -20.37 0.0053
2017-11-14 2017-09-30 13F GILEAD SCIENCES Common 375558103 18,118 -7,341 -28.83 1,468 -18.53 0.0069
2017-08-14 2017-06-30 13F GILEAD SCIENCES Common 375558103 25,459 -29,624 -53.78 1,802 -51.83 0.0086
2017-05-15 2017-03-31 13F GILEAD SCIENCES Common 375558103 55,083 -535,149 -90.67 3,741 -91.15 0.0186
2017-02-14 2016-12-31 13F GILEAD SCIENCES Common 375558103 590,232 -454,180 -43.49 42,266 -48.85 0.2300
2016-11-14 2016-09-30 13F GILEAD SCIENCES Common 375558103 1,044,412 -791,518 -43.11 82,633 -46.05 0.4242
2016-08-15 2016-06-30 13F GILEAD SCIENCES Common 375558103 1,835,930 -181,864 -9.01 153,153 -17.37 0.8086
2016-05-16 2016-03-31 13F GILEAD SCIENCES Common 375558103 2,017,794 -611,534 -23.26 185,354 -30.33 0.9388
2016-02-16 2015-12-31 13F GILEAD SCIENCES Common 375558103 2,629,328 -773,357 -22.73 266,062 -20.37 1.2939
2015-11-16 2015-09-30 13F GILEAD SCIENCES Common 375558103 3,402,685 -110,357 -3.14 334,110 -18.77 1.8233
2015-08-14 2015-06-30 13F GILEAD SCIENCES Common 375558103 3,513,042 -165,144 -4.49 411,307 13.95 1.8508
2015-05-15 2015-03-31 13F GILEAD SCIENCES Common 375558103 3,678,186 -589,047 -13.80 360,941 -10.26 1.6256
2015-02-17 2014-12-31 13F GILEAD SCIENCES Common 375558103 4,267,233 54,075 1.28 402,229 -55.11 1.9362
2014-11-14 2014-09-30 13F GILEAD SCIENCES Common 375558103 4,213,158 -700,560 -14.26 895,990 119.93 4.3573
2014-08-14 2014-06-30 13F GILEAD SCIENCES Common 375558103 4,913,718 -449,593 -8.38 407,397 7.20 2.0060
2014-05-15 2014-03-31 13F GILEAD SCIENCES Common 375558103 5,363,311 763,814 16.61 380,044 10.02 1.8837
2014-02-14 2013-12-31 13F GILEAD SCIENCES Common 375558103 4,599,497 80,230 1.78 345,422 21.57 1.7605
2013-11-14 2013-09-30 13F GILEAD SCIENCES Common 375558103 4,519,267 269,657 6.35 284,126 30.41 1.5799
2013-08-14 2013-06-30 13F GILEAD SCIENCES Common 375558103 4,249,610 4,249,610 217,878 1.2947
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.